Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,650,744
-$2,368,466 QoQ
Shares Held
465,087
-33.5% QoQ
Ownership
0.539%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 188 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Derivatives in EYPT
reported options exposure · as of Jun 30, 2026CallValue
$1,002,430
CallShares
70,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. EYPT ranks #179 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in EYPT
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,002,430 | 70,100 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $6,650,744 | 465,087 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $903,589 | 70,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $9,019,210 | 699,706 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,833,059 | 1,249,757 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $21,567,988 | 1,514,606 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,051,310 | 1,280,692 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,301,033 | 1,531,556 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $12,385,035 | 1,662,421 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,710,469 | 1,215,328 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,886,119 | 791,508 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,352,010 | 839,478 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,126,156 | 567,986 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,797,786 | 600,474 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,715,343 | 427,051 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,065,590 | 702,582 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,669,761 | 762,789 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $6,744,895 | 852,705 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $6,985,663 | 887,632 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $10,583,877 | 871,101 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,613,500 | 622,018 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $407,349 | 39,093 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,185,810 | 243,138 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,400,423 | 137,837 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $63,946 | 122,975 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $108,082 | 142,215 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $95,156 | 93,292 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||